← Back to Search

Other

ALTO-100 PO tablet for Post-Traumatic Stress Disorder

Phase 2
Waitlist Available
Research Sponsored by Alto Neuroscience
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured 5 times over 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study ALTO-100, a treatment, by collecting data on how it affects the body. Researchers are looking at biological markers to understand its effects. The study does not specify a particular patient group.

Eligible Conditions
  • Post-Traumatic Stress Disorder
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured 5 times over 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured 5 times over 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Participants With Clinically Significant Laboratory Abnormalities as a Measure of Safety and Tolerability of ALTO-100
Number of Participants With Clinically Significant Vital Signs Abnormalities as a Measure of Safety and Tolerability of ALTO-100
Number of Participants with Adverse Events (AEs) as a Measure of Safety and Tolerability of ALTO-100
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ALTO-100Experimental Treatment1 Intervention
ALTO-100 PO tablet, daily dosing 8 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ALTO-100 PO tablet
2021
Completed Phase 2
~250

Find a Location

Who is running the clinical trial?

Alto NeuroscienceLead Sponsor
10 Previous Clinical Trials
1,058 Total Patients Enrolled
~64 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top